PURPOSE: A quality of life (QoL) assessment is considered an important outcome measure in the treatment of benign thyroid diseases. The aims of this study were to analyze the impact of different surgical treatments on QoL in patients with benign thyroid diseases and to evaluate factors correlating with the QoL outcomes. METHODS: A prospective longitudinal study was conducted. One hundred thirty-two patients met the inclusion/exclusion criteria and completed the disease-specific questionnaire, thyroid patient-reported outcome (ThyPRO), before surgery and after 6 months. Preoperative and postoperative QoL outcomes were compared and correlating factors were analyzed. RESULTS: Indication for surgery was euthyroid goiter, toxic goiter, and suspicious malignant thyroid disease in 58.3, 29.5, and 12.1 % of the patients, respectively. None of the patients had overtly toxic goiter. There were 65.2 % of the patients who underwent total thyroidectomy, while 34.8 % underwent hemithyroidectomy. The total postoperative complication rate was 5.3 %. QoL improved significantly after surgical treatment, independent of the extent of performed surgery. The most affected domain, pre- and postoperative, was for tiredness. QoL improvement was significant for women in all domains, while for men, it was significant in only three domains (goiter symptoms, emotional susceptibility, and cosmetic complaints) and in overall QoL. Younger patients had significantly better cognitive functioning and daily life, while elderly patients had significantly less cosmetic complaints. The factors that significantly correlated with improvement of QoL in different domains were lower education level, duration of disease, and microcarcinoma at final histology. CONCLUSION: QoL in patients with benign thyroid diseases improves significantly after operative treatment, independent of the extent of the operation.
PURPOSE: A quality of life (QoL) assessment is considered an important outcome measure in the treatment of benign thyroid diseases. The aims of this study were to analyze the impact of different surgical treatments on QoL in patients with benign thyroid diseases and to evaluate factors correlating with the QoL outcomes. METHODS: A prospective longitudinal study was conducted. One hundred thirty-two patients met the inclusion/exclusion criteria and completed the disease-specific questionnaire, thyroid patient-reported outcome (ThyPRO), before surgery and after 6 months. Preoperative and postoperative QoL outcomes were compared and correlating factors were analyzed. RESULTS: Indication for surgery was euthyroid goiter, toxic goiter, and suspicious malignant thyroid disease in 58.3, 29.5, and 12.1 % of the patients, respectively. None of the patients had overtly toxic goiter. There were 65.2 % of the patients who underwent total thyroidectomy, while 34.8 % underwent hemithyroidectomy. The total postoperative complication rate was 5.3 %. QoL improved significantly after surgical treatment, independent of the extent of performed surgery. The most affected domain, pre- and postoperative, was for tiredness. QoL improvement was significant for women in all domains, while for men, it was significant in only three domains (goiter symptoms, emotional susceptibility, and cosmetic complaints) and in overall QoL. Younger patients had significantly better cognitive functioning and daily life, while elderly patients had significantly less cosmetic complaints. The factors that significantly correlated with improvement of QoL in different domains were lower education level, duration of disease, and microcarcinoma at final histology. CONCLUSION: QoL in patients with benign thyroid diseases improves significantly after operative treatment, independent of the extent of the operation.
Authors: B Biondi; E A Palmieri; S Fazio; C Cosco; M Nocera; L Saccà; S Filetti; G Lombardi; F Perticone Journal: J Clin Endocrinol Metab Date: 2000-12 Impact factor: 5.958
Authors: F Hubertus Schmitz-Winnenthal; Simon Schimmack; Ben Lawrence; Uwe Maier; Miriam Heidmann; Markus W Buchler; Moritz von Frankenberg Journal: Langenbecks Arch Surg Date: 2011-08-02 Impact factor: 3.445
Authors: Regina Promberger; Michael Hermann; Shanon Joan Pallikunnel; Rudolf Seemann; Moritz Meusel; Johannes Ott Journal: Am J Surg Date: 2013-09-24 Impact factor: 2.565
Authors: T V Elberling; A K Rasmussen; U Feldt-Rasmussen; M Hørding; H Perrild; G Waldemar Journal: Eur J Endocrinol Date: 2004-11 Impact factor: 6.664
Authors: David J Stott; Jacobijn Gussekloo; Patricia M Kearney; Nicolas Rodondi; Rudi G J Westendorp; Simon Mooijaart; Sharon Kean; Terence J Quinn; Naveed Sattar; Kirsty Hendry; Robert Du Puy; Wendy P J Den Elzen; Rosalinde K E Poortvliet; Jan W A Smit; J Wouter Jukema; Olaf M Dekkers; Manuel Blum; Tinh-Hai Collet; Vera McCarthy; Caroline Hurley; Stephen Byrne; John Browne; Torquil Watt; Douglas Bauer; Ian Ford Journal: BMC Endocr Disord Date: 2017-02-03 Impact factor: 2.763